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Abstract
Background: Neuropathic pain caused by peripheral nerve injury is a chronic disorder that represents a
significant clinical challenge because the pathological mechanisms have not been fully elucidated. Several
studies have suggested the involvement of various sodium channels, including tetrodotoxin-resistant
NaV1.8, in affected dorsal root ganglion (DRG) neurons. We have hypothesized that altered local
expression of NaV1.8 in the peripheral axons of DRG neurons could facilitate nociceptive signal
generation and propagation after neuropathic injury.
Results: After unilateral sciatic nerve entrapment injury in rats, compound action potential amplitudes
were increased in both myelinated and unmyelinated fibers of the ipsilateral sciatic nerve. Tetrodotoxin
resistance of both fiber populations and sciatic nerve NaV1.8 immunoreactivity were also increased.
Further analysis of NaV1.8 distribution revealed that immunoreactivity and mRNA levels were decreased
and unaffected, respectively, in the ipsilateral L4 and L5 DRG; however sciatic nerve NaV1.8 mRNA
showed nearly an 11-fold ipsilateral increase. Nav1.8 mRNA observed in the sciatic nerve was likely of
axonal origin since it was not detected in non-neuronal cells cultured from nerve tissue. Absence of
changes in NaV1.8 mRNA polyadenylation suggests that increased mRNA stability was not responsible for
the selective peripheral mRNA increase. Furthermore, mRNA levels of NaV1.3, NaV1.5, NaV1.6, NaV1.7,
and NaV1.9 were not significantly different between ipsilateral and contralateral nerves. We therefore
propose that selective NaV1.8 mRNA axonal transport and local up-regulation could contribute to the
hyperexcitability of peripheral nerves in some neuropathic pain states.
Conclusion: Cuff entrapment injury resulted in significantly elevated axonal excitability and increased
NaV1.8 immunoreactivity in rat sciatic nerves. The concomitant axonal accumulation of NaV1.8 mRNA
may play a role in the pathogenesis of this model of neuropathic pain.
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Neuropathic pain is a chronic disorder defined as pain ini-
tiated or caused by a primary lesion or dysfunction in the
nervous system [1]; it affects 1.4% of the U.S. population
and remains extremely difficult to treat, due to poorly
understood etiology and a lack of well-defined molecular
targets [2]. Several peripheral nerve injury-based rat mod-
els have been developed that exhibit various behavioral
characteristics representative of neuropathic symptoma-
tology, including hindpaw hypersensitivity to mechanical
and thermal stimuli [3]. Aberrant hyperexcitability and
ectopic burst discharge of primary sensory neurons in
these models is widely considered to be the major contrib-
utor to neuropathic pain symptomatology. Functional
studies have implicated ion channels, including sodium
channels, in this pathology. In particular, loss-of-function
studies using antisense oligodeoxynucleotides and siRNA
have highlighted the importance of the NaV1.8 tetrodo-
toxin resistant (TTX-r) sodium channel in the neurophys-
iological and behavioral effects observed in spinal nerve
ligation (SNL) and chronic constriction injury (CCI)
models of peripheral neuropathy [4-7]. Among TTX-r
sodium channels, Nav1.8 has been shown to contribute
substantially to action potential electrogenesis in dissoci-
ated DRG neurons [8,9] and is expressed in both C- and
A-fiber populations [10,11]. NaV1.8 has a higher inactiva-
tion threshold, slower inactivation kinetics, and faster
recovery from inactivation than TTX-sensitive Na+ chan-
nels [12,13], suggesting that its local upregulation could
facilitate signaling during neuropathic pain. Additionally,
it has been found that NaV1.8-null transgenic mice do not
exhibit abnormal neurophysiology in injured neuroma
tissue [14].
These and other studies have suggested that peripheral
NaV1.8 increases in sensory neuron axons contribute to
peripheral hypersensitivity. For example, in human
patients with various neuropathies such as causalgia and
brachial plexus injury, NaV1.8 has been shown to accu-
mulate in peripheral axons near the injury site [15-17]
and in a causalgic finger [18]. Increases in NaV1.8-like
immunoreactivity in axons of the rat sciatic nerve were
demonstrated after CCI [11]. Also, after SNL injury sciatic
nerve NaV1.8-like immunoreactivity increased selectively
in 'uninjured' axons; this was accompanied by increased
TTX-resistance of the C-fiber compound action potential,
suggesting a functional peripheral upregulation of NaV1.8
[5]. However, discrepancies between these findings and
the observed reduction of NaV1.8 protein and mRNA
expression in the cell bodies of injured sensory neurons
[19], as well as the normal development of neuropathic
pain behavior in NaV1.8–null mice [20,21] continue to
raise the question of what role, if any, is played by NaV1.8
in the development of neuropathic pain. Also, the mech-
anism by which peripheral translocation of NaV1.8 occurs
in the CCI model is unclear [11].
To address the mechanisms of NaV1.8 translocation and
its potential relationship to hyperexcitability, we studied
sciatic nerve excitability and NaV1.8 expression in a rat
model of painful neuropathy induced by sciatic nerve
entrapment (SNE). SNE is a variation on CCI in which the
loose ligatures placed around the sciatic nerve are replaced
by chemically inert fixed-diameter polyethylene cuffs,
resulting in decreased variability across animals [22]. We
found increased sciatic nerve axonal excitability and TTX-
resistance proximal to the injury. This was concommitant
with increased NaV1.8 immunoreactivity in proximal
axons and decreased immunoreactivity in the cell bodies
of DRG neurons on the side of the injury, analogous to
previous findings after CCI [11]. Importantly, we
observed selective and large increases in sciatic nerve
NaV1.8 mRNA in the absence of changes in NaV1.8
mRNA within DRG or changes in NaV1.8 polyadenyla-
tion. Our data collectively introduce the possibility that
NaV1.8 mRNA could be peripherally transported from the
neuronal cell bodies to the sciatic nerve and locally trans-
lated, thereby contributing to axonal hyperexcitability
and neuropathy symptoms.
Results
Sciatic nerve excitability and TTX-resistance after SNE
The CAP response amplitudes from contralateral, naïve
control nerves, and ipsilateral sham nerves were similar
and therefore grouped together. 2 weeks after SNE, the
amplitudes of both A- and C-fiber CAPs were significantly
increased in ipsilateral sciatic nerves when compared to
control, sham or contralateral nerves (Fig. 1). The
increases were observed in the plateau responses to maxi-
mal stimulation (Fig. 1A, B) Although leftward shifts in
the stimulus-response relationsips were also detected for
the A-fiber and to a lesser extent the C-fiber CAP after nor-
malizing responses to maximal amplitudes, these shifts
were not statistically significant (Fig. 1A and 1B insets).
The conduction velocity (CV) of the peak A-fiber CAP was
not different between nerves ipsilateral to SNE (32.4 ± 1.5
m/s) and control, sham or contralateral nerves (29.9 ± 1.7
m/s). The CV of the ipsilateral C-fiber CAP 1.2 ± 0.1 m/s)
was also similar to that of control, sham and contralateral
nerves (1.1 ± 0.1 m/s).
Concentration-dependent decreases in CAP amplitude
were detected within 30 sec after TTX (0.1–1 μM) was
applied in the recording chamber (p < 0.05, two-way
ANOVA with Tukey post-hoc) and measurements were
obtained after 20–25 min to ensure a full drug response.
The C-and A-fiber CAPs in both injured and uninjured
nerves were blocked completely in the presence of 1 μM
TTX (not shown). At lower concentrations, the TTX-resist-Page 2 of 12
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cantly increased in nerves ipsilateral to SNE (p < 0.05,
two-way ANOVA with Tukey post-hoc) (Fig. 2A, B).
Peripheral nerve NaV1.8 immunoreactivity after SNE
At two weeks after SNE injury, NaV1.8-like immunoreac-
tivity in the ipsilateral L4 and L5 dorsal root ganglia
(DRG) was reduced (Fig. 3A, B). Specifically, the staining
intensities of NaV1.8+ small-, medium-, and large diame-
ter neurons were all significantly decreased (p < 0.05, one-
way ANOVA with Tukey post-hoc; Fig. 3B). In marked
contrast to the DRG, NaV1.8-like immunoreactivity
increased more than two-fold in ipsilateral nerves (p <
0.05, t-test; Fig. 3C, D).
Detection of NaV1.8 mRNA in sciatic nerves
Real-time PCR detected the presence of NaV1.8 mRNA in
the sciatic nerve and revealed a significant up-regulation
in the ipsilateral nerve as compared to the contralateral
and uninjured nerve (p < 0.05, one-way ANOVA with
Tukey post-hoc; Fig. 4A). In contrast, ipsilateral, contralat-
eral, and uninjured DRG showed no significant differ-
ences in NaV1.8 mRNA levels (Fig. 4B). To confirm that
the NaV1.8 PCR signals represent mRNA and not genomic
DNA contamination, 3'RACE PCR was performed. South-
ern blot hybridization analysis showed a positive band at
the predicted size of 830 bp in both contralateral and ipsi-
lateral sciatic nerve samples (Fig. 4C). After agarose gel
separation and cloning of amplicons, DNA sequencing
positively identified the 3' end of the coding region and
Increased excitability of ipsilateral sciatic nerve after SNEFigure 1
Increased excitability of ipsilateral sciatic nerve after 
SNE. A: Stimulus-output plot of A-fiber CAP peak for sciatic 
nerve ipsilateral to SNE (n = 8) compared to preparations 
from contralateral, naïve or sham control rats (n = 8). Inset 
(left) shows examples of ipsilateral and contralateral A-fiber 
CAP with peaks aligned for clarity (0.1 mA stimulus). *, p < 
0.05 (two-way ANOVA, Tukey post-hoc). Inset (bottom 
right) shows normalized data with error bars removed for 
clarity. Note the leftward shift of data from ipsilateral nerves. 
B: Stimulus-output plot of C-fiber CAP peak for sciatic nerve 
ipsilateral to SNE compared to preparations from contralat-
eral, naïve or control rats. Inset (left) shows examples of ipsi-
lateral and contralateral C-fiber CAP (10 mA stimulus). Inset 
(bottom right) shows normalized data with error bars 
removed for clarity. Stimulus durations were 0.1 ms and 0.5 
ms for A- and C-fiber CAP, respectively throughout. Tissue 
was harvested 2 weeks after SNE or sham surgery.
Increased TTX-resistance of the sciatic nerve after SNEFigure 2
Increased TTX-resistance of the sciatic nerve after 
SNE. A: TTX-resistance of the A-fiber sciatic nerve com-
pound action potential (CAP) ipsilateral to SNE (n = 8) com-
pared to contralateral, naïve and sham surgery nerves (n = 
8). CAP response is expressed as a % of recorded amplitude 
before TTX administration. A-fiber CAP stimulus was 0.1 
mA, 0.1 ms throughout. B: Changes in TTX-resistance of the 
C-fiber sciatic nerve CAP after SNE. C-fiber CAP stimulus 
was 10 mA, 0.5 ms throughout. * indicates significant differ-
ence from control nerve sensitivity to TTX (p < 0.05, two-
way ANOVA, Tukey post-hoc). Tissue was harvested 2 
weeks after SNE or sham surgery.Page 3 of 12
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tional poly A tail (data not shown).
Evidence for neuronal origin of NaV1.8 mRNA in sciatic 
nerve
We hypothesized that if sciatic nerve NaV1.8 mRNA was
of non-neuronal origin, it would be detectable in cultures
of dissociated sciatic nerves where there are no neuronal
somata and neuronal axons have degenerated. No real-
time PCR signal was detected for NaV1.8 in sciatic nerve
cultures (Fig 5A, C), whereas robust NaV1.8 expression
was observed in DRG cultures that served as a positive
control (Fig. 5B, C). However, similar signals for 18s rRNA
were detected in the sciatic nerve and DRG cultures (Fig.
5D), suggesting similar concentrations of template cDNA.
Additionally, we were able to detect strong expression of
s100B, a Schwann cell marker, in both sciatic nerve and
DRG cultures, with Ct values ranging from 26–30. Inter-
estingly, although s100B expression was strong in nerve
cultures, it was still stronger in DRG cultures (Fig. 5E).
Selectivity of peripheral nerve NaV1.8 mRNA up-
regulation after SNE
After confirmation of the presence of NaV1.8 mRNA in
the sciatic nerve, we compared steady-state levels of
mRNA for NaV1.3, NaV1.5, NaV1.6, NaV1.7, NaV1.8, and
NaV1.9 between ipsilateral and contralateral segments of
the sciatic nerve immediately proximal to the injury site
(Fig. 6A). Ipsilateral NaV1.8 mRNA was significantly up-
regulated by 10.8-fold (p < 0.05, Mann-Whitney). Ipsilat-
eral NaV1.6 mRNA expression was increased by 3.48-fold,
but this difference did not reach statistical significance (p
> 0.05, Mann-Whitney). None of the other sodium chan-
nels showed significant up-regulation in the sciatic nerve
(p > 0.05, Mann-Whitney). We further examined mRNA
expression of the same sodium channels in the DRG at the
same time point. Ipsilateral NaV1.5, NaV1.6, NaV1.7, and
NaV1.9 mRNA levels decreased by 28.6%, 39.8%, 54.1%,
and 54.9%, respectively, however only the decrease was
only statistically significant for NaV1.7 (p < 0.05, Mann-
Whitney; Fig. 6B).
Polyadenylation of peripheral NaV1.8 mRNA
To investigate potential inhibition of peripheral NaV1.8
mRNA degradation by polyadenylation, we conducted the
polyA tail length assay as originally described by Salles
and Strickland [23]. NaV1.v8 mRNA isolated from both
injured nerve and uninjured DRG primarily exhibited a
discrete polyA tail of about 50 bases, with additional poly-
adenylation occurring out to 200 bases (Fig. 7). However,
there were no apparent differences in the maximum polyA
tail length or smearing pattern.
Discussion
The NaV1.3, NaV1.8, and NaV1.9 sodium channels are
differentially regulated after nerve injury [24], and the
TTX-resistant NaV1.8 and NaV1.9 are selectively distrib-
uted in peripheral sensory neurons [24]; these properties
have identified them as potential molecular targets for
neuropathic pain. Antisense oligodeoxynucleotide and
siRNA studies suggest that sensory neuron NaV1.8 expres-
sion and spinal cord NaV1.3 expression are important for
behavioral phenotypes and aberrant neurophysiology in
rats with peripheral nerve injuries [4-7,25]. Rat loss-of-
function studies have not yet been performed for NaV1.9,
but studies of NaV1.9-null transgenic mice suggest
involvement in inflammatory rather than neuropathic
pain [26,27].
The requirement of NaV1.8 and NaV1.3 for neuropathic
pain remains controversial, however, as neuropathic pain
behavior develops normally in NaV1.8- and NaV1.3-null
mice [20,21,28], as well as in mice treated with diptheria
toxin to selectively destroy all postmitotic sensory neu-
rons expressing NaV1.8 [29]. It is possible that the dis-
crepancy between these findings and those of rat loss-of-
NaV1.8 protein is down-regulated in the DRG and up-regu-lated in the nerve after SNEFigure 3
NaV1.8 protein is down-regulated in the DRG and 
up-regulated in the nerve after SNE. A: Nav1.8-ir in 
representative DRG sections after SNE. B: Quantification of 
fluorescence intensity in DRG neurons. Neurons are classi-
fied by cell area. h: contralateral. ▪: ipsilateral. DRG measure-
ments were from 3 contralateral and 6 ipsilateral sections (n 
= 3. *; p < 0.05, one-way ANOVA, Tukey post-hoc). C: 
NaV1.8-ir in representative sections of sciatic nerve after 
SNE. D: Quantification of fluorescence intensity in sciatic 
nerve. Measurements were made from 8 contralateral and 8 
ipsilateral sections. (n = 3, *; p < 0.05, t-test). Scale bar: 100 
μm for A and C. Tissue was harvested 2 weeks after SNE. 
For both DRG and nerve sections, average intensity was 
measured using ImageJ software. Output intensity values 
were on a 0–255 scale based on the 255 shades of grey 
present in the image, with 0 representing black and 255 rep-
resenting white. The output numerical intensity value was 
defined as "relative fluorescence."Page 4 of 12
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NaV1.8 or NaV1.3 deletion, as well as species differences,
although it has also been shown that intrathecal antisense
knockdown of NaV1.3 did not reverse pain symptoms in
a rat spared nerve injury (SNI) model [30].
We hypothesized that SNE injury would produce sensory
neuron hyperexcitability which would be related to
altered local expression of NaV1.8. We found that SNE
injury in rats induced a unique electrophysiological phe-
notype characterized by increased sciatic nerve CAP
amplitude in both C- and A-fiber populations (Fig. 1). The
C-fiber increase likely contributed to the thermal hyper-
sensitivity we have previously observed in this model,
while Aδ-fiber excitability would be expected to contrib-
ute to the observed mechanical hypersensitivity [31].
However, the overall magnitude of the A-fiber CAP
increase and lack of change in conduction velocity suggest
increased excitability of Aβ-fibers instead of or in addition
to Aδ-fibers. Aβ-fibers are not normally involved in nocic-
eption [32] with the exception of a small subpopulation
[33], but phenotypic changes in Aβ-fibers have been
reported after nerve injuries including SNE [34,35] that
result in nociceptive afterdischarge in spinal wide
dynamic range neurons [35]. It is possible that such a phe-
notypic switch might have been involved in the observed
A-fiber CAP enhancement and concomitant mechanical
or thermal hypersensitivity.
It is notable that increased A- and C-fiber CAP amplitudes
persisted even after the stimulus-output plot reached a
plateau (Fig. 1). Because increased CAP amplitude is typi-
cally interpreted as a recruitment of more axons, a stimu-
lus-output plateau suggests that all available axons have
been recruited. A further CAP increase could potentially
arise from a change in the total number of axons; how-
ever, after SNE the numbers of large- and small-diameter
afferents do not change proximal to the injury site, where
the recorded tissues were sampled [22]. It is therefore
more likely that the observed CAP increase represents
peripherally increased Na+ conductance in individual
axons. It is further likely that such an increase in conduct-
ance would be at least partially mediated by TTX-resistant
channels, as CAP TTX resistance increased concomitantly
with CAP amplitude for both C- and A-fibers after SNE
injury (Fig. 2). An alternative explanation for these obser-
vations is that increased expression of TTX-sensitive Na+
channels could increase both the CAP amplitudes and the
safety factor for axonal action potential conduction dur-
ing TTX application. Another possibility we considered
was the upregulation of a third TTX-R channel, Nav1.5,
which is normally expressed in sensory neurons during
development but declines to very low levels at birth and
adulthood [36]. Nav1.5 exhibits faster kinetics than
Nav1.8 and is significantly more sensitive to TTX (IC50 ~2μM) than Nav1.8 or Nav1.9 [36]; thus upregulation of
Nav1.5 could potentially account for the observed
increases in TTX-resistance, including the blockade of A
and C-fiber CAP conduction by 1 μM TTX after SNE. How-
ever, we did not observe increased NaV1.5 mRNA expres-
sion in the DRG or the sciatic nerve after SNE.
Detection of NaV1.8 mRNA in the sciatic nerveFigure 4
Detection of NaV1.8 mRNA in the sciatic nerve. A. NaV1.8 mRNA levels were significantly increased in the sciatic nerve 
ipsilateral to the injury site as compared to contralateral and uninjured DRG. (n = 3; p < 0.05, one-way ANOVA with Tukey 
post-hoc). B. NaV1.8 mRNA levels in SNE-injured DRG were not significantly different from those of uninjured DRG (n = 4 for 
uninjured DRG and n = 3 for all other samples). C: Southern blot of the Nav1.8 3' RACE product from contralateral and ipsi-
lateral sciatic nerve. Note the presence of a distinct band representing the expected 3'RACE product of 830 bp. Sequencing of 
the RACE product confirmed the presence of the 3' end of the NaV1.8 coding region as well as the NaV1.8 3' un-translated 
region and polyA tail. Tissue was harvested 2 weeks after SNE.Page 5 of 12
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C-fibers (resistant to block by 100 μM TTX), were reported
for the SNL model [5], underscoring major differences
between the SNE and SNL models. SNL is thought to
cause extensive Wallerian degeneration of injured axons
from L5 and L6 DRG, leaving only uninjured L4 axons in
the sciatic nerve [5]. In contrast, CCI and SNE cause selec-
tive degeneration of Aβ-fibers distal to the constriction
site with some remyelination occurring 2–4 weeks after
injury [37,38]; this partial, distal degeneration leaves
proximal injured and uninjured axons structurally intact.
We also found that sciatic nerve NaV1.8 immunoreactiv-
ity was increased after SNE injury, while immunoreactiv-
ity within cell bodies of DRG sensory neurons ipsilateral
to SNE was reduced. Similar findings were previously
reported for the CCI model [11], underscoring simmilari-
ties with SNE. This peripheral translocation of Nav1.8
together with increased TTX-resistance suggests involve-
ment of peripherally accumulated NaV1.8 in sciatic nerve
hyperexcitability after SNE injury.
Several mechanisms may underly the peripheral translo-
cation of NaV1.8 protein observed in multiple injury
models. In the present study, we detected ipsilaterally
decreased DRG NaV1.8 immunoreactivity (Fig. 3), but
NaV1.8 mRNA levels in the DRG were not affected by SNE
injury (Figs. 4 &5). Similar post-CCI immunohistochemi-
cal redistribution of NaV1.8 to sciatic nerve axons without
increased DRG mRNA expression previously led Novako-
vic et al. to suggest peripheral trafficking of existing
NaV1.8 protein with increased local insertion [11].
Decreased NaV1.8 mRNA levels and attenuated NaV1.8
currents that could be compatible with such a mechanism
were also observed in injured small-diameter DRG
somata cultured from CCI-injured rats [39]; NaV1.8 pro-
tein levels in injured neurons within the DRG were also
shown to decrease in rats after SNL, CCI, SNI, and axot-
omy injuries [24]. However, while the majority of de novo
protein synthesis is believed to occur in DRG somata, an
increasing number of studies suggest that axons contain
mRNAs such as β-actin, cofilin and RhoA that are locally
translated in response to guidance cues during nervous
system development [40-42]. Recently, intra-axonal CREB
mRNA translation was shown to be essential for neuronal
survival in response to nerve growth factor application
[43]. We thus hypothesized that axonal NaV1.8 mRNA
accumulation might contribute to the increased immuno-
reactivity in the nerve proximal to SNE injury.
To address this hypothesis, we first determined the pres-
ence of NaV1.8 mRNA in the sciatic nerve using RT-PCR
(Fig. 4 &5; also see [44]. The 3'RACE sequencing identi-
fied a polyA tail in NaV1.8 PCR amplicons, suggesting
that our PCR data did not reflect genomic DNA contami-
nation. In addition, we determined the cellular origin of
NaV1.8 transcripts because sciatic nerve contains non-
neuronal cells such as Schwann cells and fibroblasts in
addition to neuronal axons. Cells cultured from both
naïve DRG and sciatic nerve showed expression of s100B,
confirming the presence of Schwann and/or satellite 'glial'
cells. However, NaV1.8 expression was not detected in the
nerve cultures (Fig. 6), suggesting that NaV1.8 transcripts
detected in intact nerve tissue were likely derived from
axons.
Significant up-regulation of NaV1.8 mRNA was demon-
strated in the ipsilateral sciatic nerve when compared to
the contralateral or uninjured nerve (Fig. 4). To explore
the mechanism of the peripheral NaV1.8 mRNA increase,
we examined the polyadenylation state. There were no dif-
Axonal origin of sciatic nerve NaV1.8 mRNAFigure 5
Axonal origin of sciatic nerve NaV1.8 mRNA. A, B: 
Representative images of cells cultured from the sciatic nerve 
and dorsal root ganglia. Cells with Schwann- and fibroblast-
like morphology were present in both nerve and DRG cul-
tures, whereas neurons were only present in the DRG cul-
ture. C: Expression of 18s rRNA in nerve and DRG cultures 
(n = 3). Expression is given in terms of the absolute cycle 
count where signal was first detected. D. Expression of 
NaV1.8 mRNA in nerve and DRG cultures (n = 3). Relative 
expression was normalized externally against the DRG sam-
ple with the lowest NaV1.8 expression and internally against 
18s expression rRNA expression. E. Expression of s100B 
mRNA in nerve and DRG cultures (n = 3). Relative expres-
sion was normalized externally against the nerve sample with 
the lowest s100B expression and internally against 18s 
expression rRNA expression. Strong expression was 
observed in both cultures with Ct values of 26–30. However, 
relative expression was still higher in DRG cultures.Page 6 of 12
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ing pattern between injured nerve and uninjured DRG
samples (Fig. 7). Therefore, intra-axonal polyadenylation
resulting in reduced turnover and increased steady-state
mRNA levels [45] was ruled out as a mechanism of
increased NaV1.8 mRNA accumulation in SNE axons.
Strikingly, simultaneous analysis of multiple sodium
channels further demonstrated that after SNE injury,
steady-state NaV1.8 mRNA was significantly increased in
the ipsilateral nerve by nearly 11-fold when compared to
the contralateral nerve. In contrast, we were unable to
observe any changes in ipsilateral mRNA levels of NaV1.3,
NaV1.6, NaV1.7, or NaV1.9 (Fig. 5). It is unlikely that the
selective NaV1.8 mRNA increase was the indirect result of
ultrastructural changes, as both the fiber number and
composition remain unaltered at the sampling location
proximal to the injury site [37]. These findings thus sug-
gest a novel mechanism of selective NaV1.8 mRNA accu-
mulation in injured axons.
A recent study of rat saphenous nerve neuromas revealed
increased local translation of structural and metabolic
proteins, although no changes were observed in the
steady-state protein levels of NaV1.8, NaV1.3, or the α 2δ
calcium channel [46]. It has also been shown that axon-
ally transported importin β and vanilloid receptor mRNAs
can be locally translated in sciatic nerve axons after nerve
injury and dorsal horn synaptic terminals during inflam-
mation, repsectively [47,48]. Various mRNAs coding
cytoskeletal and metabolic proteins have been found to
be axonally transported and locally translated in a cul-
tured axonal preparation [49]. Thus, we propose here that
enhanced and selective peripheral transport is the most
likely mechanism for axonal NaV1.8 mRNA up-regula-
tion, and that local mRNA accumulation could contribute
to the observed increase in sciatic nerve NaV1.8 immuno-
reactivity. Our findings also support the involvement of
peripheral NaV1.8 protein in sciatic nerve hyperexcitabil-
ity after neuropathic injury.
Conclusion
While our experimental design did not permit the direct
discrimination of somatically- and axonally-derived pro-
tein, our findings collectively introduce the possibility
that sodium channel mRNA could be peripherally trans-
Selective peripheral translocation of NaV1.8 mRNA after SNE injuryFigure 6
Selective peripheral translocation of NaV1.8 mRNA after SNE injury. A: Sodium channel mRNA levels in naive, con-
tralateral, and ipsilateral sciatic nerve. Black columns: ipsilateral side. White columns: contralateral side. B: Sodium channel 
mRNA levels in contralateral and ipsilateral L4 and L5 DRG. Black columns: ipsilateral side. Grey columns: contralateral side. 
Note that NaV1.8 showed a significant 10.8-fold increase in the ipsilateral sciatic nerve (*; p < 0.05, Mann-Whitney) and that 
this increase did not occur in the DRG. NaV1.6 showed a 3.48-fold increase in the nerve, but this did not reach statistical sig-
nificance (p = 0.19, Mann-Whitney). NaV1.5 showed an 80.2% decrease in the ipsilateral nerve, but this also did not reach sta-
tistical significance (p = 0.079, Mann-Whitney) Ipsilateral NaV1.5, NaV1.6, NaV1.7, and NaV1.9 mRNA levels decreased by 
28.6%, 39.8%, 54.1%, and 54.9%, respectively, but the downregulation only reached statistical significance for NaV1.7 (p < 0.05, 
Mann-Whitney). All samples were normalized externally against the mean contralateral expression and internally against 18s 
rRNA expression (n = 3–7). Means and standard errors are shown for convenience; parametric analyses of non-parametric 
data returned similar results.Page 7 of 12
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lated. If this is the case, the local up-regulation of NaV1.8
mRNA shown here after injury may at least partially con-
tribute to the observed peripheral increases in NaV1.8
protein levels and nerve excitability, which in turn may
play a role in the aberrant nociception that characterizes
neuropathic pain.
Methods
Sciatic nerve entrapment (SNE)
Surgery was performed as described previously [22] using
adult male Sprague-Dawley rats weighing 200–250 g.
Briefly, three Tygon® cuffs (length = 1 mm, outer diameter
= 2.28 mm, inner diameter = 0.76 mm) were placed
around the exposed sciatic nerve proximal to the trifurca-
tion.
Immunohistochemistry
At 2 weeks after injury, rats were anesthetized with pento-
barbital (100 mg/kg, i.p.) and fixed by intracardiac per-
fusion of 500 ml ice-cold 4% paraformaldehyde and
0.14% picric acid in 0.1 M phosphate buffer (PB), pH 7.4.
Ipsilateral and contralateral L4 and L5 DRG were har-
vested along with sciatic nerve segments. Tissue was post-
fixed for 24 hrs and cryoprotected overnight in 30%
sucrose in 0.1 M PB. Samples were mounted in Tissue-Tek
(Sakura Finetek USA, Inc., Torrance, CA), and cryosec-
tioned at 25 μm (DRG) or 20 μm (sciatic nerve). Free-
floating sections were incubated overnight with an anti-
NaV1.8 antibody (1:2000 dilution, in PBS containing 5%
NGS and 0.3% Triton X-100). The NaV1.8 antibody,
which was previously extensively characterized, 15 was
generously provided by Dr. John Wood, London, UK. Sec-
tions were then incubated in a FITC-labeled goat anti-rab-
bit secondary antibody (Molecular Probes, Carlsbad, CA)
at 1:500 dilution. The sections were mounted in an anti-
fade medium (ProLong, Molecular Probes, Carlsbad, CA).
To minimize variability between specimens, ipsilateral
and contralateral tissues were processed simultaneously
and representative sections grouped on the same slides.
Confocal Microscopy
Confocal fluorescence images were taken at 20× magnifi-
cation on a Leica TCS-SP confocal fixed-stage upright
microscope (Heidelberg, Germany) equipped with argon
(488 nm excitation: JDS Uniphase) and DPSS diode (561
nm excitation: Melles-Griot) lasers. All laser excitation
and detection parameters were kept constant across all
samples. Image stacks were averaged and given identical
high and low intensity thresholds using LCS lite software
(Leica, Heidelberg, Germany). For DRG images, neuronal
area was measured by outlining NaV1.8 immunoreactive
somata and then calculating the area with ImageJ software
http://rsb.info.nih.gov/ij/. Fluorescence intensity was
measured by outlining the cytosolic region of NaV1.8
immunoreactive somata; outlines were in the shape of an
annulus, to exclude the darker nuclei. Average cytosolic
fluorescence intensity was then measured using ImageJ
software. When overlapping NaV1.8-immunoreactive
somata were detected, the overlapping regions were
NaV1.8 mRNA polyadenylation does not increase in the injured sciatic nerveFigure 7
NaV1.8 mRNA polyadenylation does not increase in the injured sciatic nerve. A: Schematic representation of PolyA 
Tail (PAT) assay. 1. Reverse transcription with oligo dT-Adaptor primer. 2. NaV1.8-specific PCR amplification with Adaptor 
primer. Amplicon length depends on polyA tail length. 3. Southern blot detection with digoxygenin (DIG)-labeled NaV1.8-spe-
cific probe after gel electrophoresis. Multiple polyA tail lengths result in smearing and multiple bands. B: Southern blot of PAT 
amplicons. : NaV1.8 mRNA from both ipsilateral nerve and uninjured DRG tissue predominantly exhibits a discrete polyA tail 
< 50 bases long, with additional polyadenylation occurring out to 200 bases. Tissue was harvested 2 weeks after SNE.Page 8 of 12
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ses, 1–2 111 × 320 pixel rectangles were drawn on each
image such they did not cover any gap, break, or artifact.
The average intensity within each rectangle was measured
using ImageJ software. For both DRG and nerve sections,
output intensity values were on a 0–255 scale based on
the 255 shades of grey present in the image, with 0 repre-
senting black and 255 representing white. The output
numerical intensity value was defined as "relative fluores-
cence."
Surgery, tissue collection and preparation for 
electrophysiology
At 2 weeks after injury, rats were anesthetized with
sodium pentobarbital (50 mg/kg) and L4 and L5 DRG
were excised with their dorsal roots, the ventral roots, the
spinal nerves and a length of attached sciatic nerves cut
just proximal to the site of entrapment. The preparations
were further trimmed at 0–4°C in the low-Na+ artificial
cerebrospinal fluid (ACSF) composed of (in mM): NaCl,
62; KCl, 3.5; NaH2PO4, 1.25; CaCl2, 2; MgCl2, 2;
NaHCO3, 26; glucose, 10 and sucrose, 124. Isolated DRG
and sciatic nerve sections were then placed in cryogenic
vials, frozen in liquid nitrogen and stered at -80°C. Alter-
natively, sections of sciatic nerve were then transferred to
normal ACSF (20–23°C) composed of (in mM): NaCl,
124; KCl, 3.5; NaH2PO4, 1.25; CaCl2, 2; MgCl2, 2;
NaHCO3, 26 and glucose, 10. The ACSF was continuously
bubbled with a 95/5% mixture of O2/CO2. For recording,
preparations were transferred to a custom recording
chamber (0.3 ml volume) that was perfused (2.7 ml/min)
with oxygenated ACSF at 34.5°C. TTX (0.1–1 μM, Sigma)
was dissolved and applied in ACSF.
Compound action potential recording
Compound action potentials (CAPs) were recorded from
the sciatic nerves using a suction recording electrode
[50,51]. Signals from the recording electrode and the arti-
fact suppression electrode were fed into a differential
amplifier (Dam 50, WPI, Sarasota, FL) in AC mode. A cal-
ibration pulse (± 2 V across a 100 MΩ series resistor) was
always included in the CAP recordings to estimate the
resistance at the nerve/recording electrode junction
[50,51]. Signals from CAP recordings were further ampli-
fied (Brownlee Precision Instruments, model 440, Santa
Clara, CA). Amplified signals were digitized at 10–20 kHz
via the Digidata 1200B interface (Molecular Devices,
Union City, CA) and displayed on a computer screen
using the pCLAMP 8 software package (Molecular
Devices). Data were analyzed offline using the pCLAMP 8
software package (Molecular Devices). Since CAP ampli-
tude/area varies linearly with changes in this resistance
[50,51], the CAP signal was adjusted based on the calibra-
tion pulse amplitude changes during analysis of any given
recording. All data are presented as mean ± standard error
of the mean (SEM).
Cell Culture
Sciatic nerve sections and lumbar DRG were extracted as
above and cut into small pieces in ice-cold Hank's bal-
anced salt solution (HBSS) with 20% fetal bovine serum
(FBS). The tissue was incubated for 75 min at 37°C in
HBSS with 0.125% collagenase P (Roche, Indianapolis,
IN), and 0.05% DNAse. 0.25% trypsin was added for 5
min, after which the tissue was centrifuged for 5 min at
2000 rpm. After washing with 20% FBS in HBSS, the cell
pellet was resuspended in HBSS containing 0.295%
MgSO4 and 0.05% DNAse. The tissue was then triturated
10 times with a fire-polished siliconized Pasteur pipette
and centrifuged for 5 min at 2000 rpm. The resulting cell
pellet was resuspended in 1 ml of F12 nutrient mixture
with 10% FBS, and 300 μl were plated into each of 3 wells
of a 12-well cell culture plate. The plate was incubated at
37°C for 1 hr, and then another 700 μl of medium was
added. The medium was then changed every 2 days. After
4 days, culture plates were washed in PBS, snap-frozen in
liquid nitrogen, and then stored at -80°C. For RNA extrac-
tion, culture plates were thawed, and 350 μl of buffer RLT
from the RNEasy Plus Mini Kit (Qiagen, Valencia, CA)
were immediately added to each well. Wells were incu-
bated for 15 minutes at room temperatue and scraped
with pipette tips. The buffer RLT containing scraped cells
from each well was then placed into separate RNAse-free
1.5 mL microcentrifuge tubes. The RNEasy Plus protocol
with gDNA eliminator columns was then followed for
RNA extraction.
Quantitative real-time reverse-transcription polymerase 
chain reaction
At 2 weeks after injury, rats were anesthetized (50 mg/kg
pentobarbital, i.p.), and ipsilateral L4 and L5 DRG were
harvested together with sciatic nerve segments. RNA was
extracted using a combination of phenol/chloroform
extraction and glass fiber purification (Trizol, Invitrogen,
Carlsbad, CA, and RNAqueous, Ambion, Austin, TX),
DNAse treated (Ambion, Austin, TX), and reverse-tran-
scribed (Superscript III, Invitrogen, Carlsbad, CA) using
random hexamer primers. Samples were subjected in trip-
licate to real-time PCR under default cDNA conditions
(Applied Biosystems, Foster City, CA) using a ready-made
18s rRNA primer and probe set (Applied Biosystems, Fos-
ter City, CA) as an internal control. Ready-made Taqman
expression assay sets (Applied Biosystems, Foster City,
CA) were used for PCR amplification of various sodium
channel cDNAs; the expression assay IDs were: NaV1.3,
Rn00565438_m1; NaV1.5, Rn00565502_m1; NaV.16,
Rn00570506_m1; NaV1.7, Rn00581647_m1; NaV1.8,
Rn_00568393; NaV1.9, Rn00570487_m1.Page 9 of 12
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At 2 weeks after injury, total RNA (800 ng) extracted sep-
arately from ipsilateral and contralateral sciatic nerve was
converted to first strand cDNA and then subjected to
3'RACE PCR using the SMART RACE cDNA Amplification
Kit (Clontech, Mountain View, CA). The anchoring
primer for the 3'RACE PCR reaction was 5'-GTTTAT-
GGCGACAATCTCTCCAAAG-3' (Tm = 65°C), located
approximately 830 bp upstream of the NaV1.8 mRNA
polyA tail. Approximately 18 ng of first strand cDNA tem-
plate was consistently used for all samples. Samples were
denatured at 94°C for 30 sec, annealed at 68°C for 30 sec,
and elongated at 72°C for 3 min. First strand cDNA was
amplified for 35 cycles with the anchoring primer and
oligo d(T) primer. Southern blot hybridization analysis
was used to identify positive PCR amplicons containing
NaV1.8 3'end sequence. The DIG-labeled DNA probe
against the NaV1.8 3' end coding sequence was synthe-
sized using the PCR DIG Probe Synthesis Kit (Roche, Indi-
anapolis, IN) with forward primer 5'-
GGAAGACCTCTCAGCCACAG-3' and reverse primer 5'-
CAGGGTGTTGGAGAGTGTCA-3'. After hybridization,
the membrane was washed, blocked, incubated with anti-
DIG antibody, and detected according to the manufac-
turer's instructions. Chemiluminescence was detected by a
LAS-3000 Luminescent Image Analyzer (Fujifilm, Tokyo,
Japan). 18S ribosomal RNA was amplified from the con-
tralateral and ipsilateral sciatic nerve RNA samples for use
as an internal control during PCR.
PolyA tail length assay
At 2 weeks after injury, total RNA was extracted as
described above. Reverse transcription was performed
using 5'-GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT-3'
as the primer. Reaction mixtures were prepared on a block
heated to 94°C and then subjected to 35 cycles of PCR
amplification using high fidelity Ex Taq polymerase
(Takara, Otsu, Japan). Each cycle consisted of 30 sec dena-
turation, 1 min annealing, and 2 min extension. The
primers were 5'-ACTCCTCCATTCTGACGTCCCTTCC-3'
and 5'-GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT-3,'
and the annealing temperature was 68°C.
Digoxigenin-labeled probes were generated by PCR using
a standard kit and protocol (Roche). The primers were 5'-
TTACCGGCTGAGTGTCCATAACAGG-3' and 5'-CATTCT-
GACGTCCCTTCCGAGTTCC-3', and the annealing tem-
perature was 66°C. PCR amplicons from the PolyA tail
length assay were run on a 1.5% agarose gel, transferred
and cross-linked to a positively charged nylon membrane
by UV light. After probe hybridization, the membrane was
washed and blocked with a standard kit (Roche, Indiana-
polis, IN), and 1:10000 Anti-Digoxigenin-AP conjugate
was applied. The membrane was washed again and devel-
oped with CDP-Star (Roche, Indianapolis, IN). The mem-
brane was exposed for 0.5–15 min and developed.
Statistical analysis
Ipsilateral and contralateral data sets were checked for
normality using Shapiro-Wilkes and Liliefors tests, with p
< 0.05 accepted as a non-normal distribution. Compari-
sons of two groups with normal distributions were made
using Student's t-test. Comparisons of a non-normally
distributed group with any other group were made using
the Mann-Whitney U test. Comparisons of more than two
groups, all of which were normally distributed, were
made using 1-way ANOVA with Tukey post-hoc tests for
pairwise comparisons. Two-way ANOVA with Tukey post-
hoc tests was used for behavioral and electrophysiological
data where a second variable (i.e. stimulus strength or
time point) was analyzed simultaneously with laterality
(i.e. ipsilateral vs. contralateral).
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